Minerva Neurosciences | NERV - Vermögenswerte





Vermögenswerte Veränderung Datum
Acadia Pharmaceuticals USD 1.74B 137.67M 2026-06
Adma Biologics USD 732.48M 48.28M 2026-09
ALKERMES USD 4.44B 42.4M 2026-09
Alterity Therapeutics Limited AUD 37.98M 15.78M 2025-12
AstraZeneca USD 119.92B 4.09B 2026-09
BioCryst Pharmaceuticals USD 591.07M 33.22M 2026-09
Bristol-Myers Squibb USD 88.77B 1.14B 2026-09
Cipla INR 434.34B 9.38B 2026-09
Clal Biotechnology ILS 158.39M 24.3M 2023-12
Compugen USD 138.36M 7.5M 2026-06
CSL USD 37.9B 1.5B 2025-12
Eli Lilly USD 148.07B 5.79B 2026-09
GlaxoSmithKline GBP 71.7B 9.96B 2026-09
Grifols EUR 23.15B 142.7M 2025-12
Halozyme Therapeutics USD 2.58B 95.31M 2026-06
Ionis Pharmaceuticals USD 2.99B 455.5M 2026-06
J&J USD 197.42B 3.64B 2026-09
Merck USD 132.77B 2.97B 2026-09
Minerva Neurosciences USD 97.97M 69.88M 2025-12
Neurocrine Biosciences USD 5.63B 268.3M 2026-09
Novartis USD 117.15B 4.88B 2026-09
Novavax USD 955.58M 87.59M 2026-06
Pfizer USD 204.54B 3.41B 2026-09
Roche Holding CHF 98.2B 2.5B 2026-06
Sanofi EUR 130.29B 1.23B 2026-09
Takeda JPY 15.27T 391.77B 2026-09
Vanda Pharmaceuticals USD 488.95M 112.19M 2025-12